CDT Equity Inc.
$3.35
▼
-22.85%
2026-04-21 05:58:00
www.conduitpharma.com
NCM: CDT
Explore CDT Equity Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$16.81 M
Current Price
$3.35
52W High / Low
$3,030 / $2.6
Stock P/E
—
Book Value
$83.78
Dividend Yield
—
ROCE
230.89%
ROE
491.09%
Face Value
—
EPS
$-397.65
Exp Qtr EPS
—
Sector
Healthcare
Industry
Biotechnology
Employees
6
Beta
2.08
Debt / Equity
43.83
Current Ratio
1.66
Quick Ratio
0.25
Forward P/E
—
Price / Sales
—
Enterprise Value
$-1.7 M
EV / EBITDA
0.1
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Regeneron Pharmaceuticals, Inc. | $753.59 | 17.99 | $79.36 B | 0.5% | 10.23% | 14.86% | $821.11 / $476.49 | $304.65 |
| 2. | Disc Medicine, Inc. | $71.41 | — | $2.74 B | — | -30.64% | -35.86% | $99.5 / $39.2 | $19.52 |
| 3. | MoonLake Immunotherapeutics | $17.89 | — | $1.32 B | — | -64.61% | -60.78% | $62.75 / $5.95 | $4.27 |
| 4. | Artiva Biotherapeutics, Inc. | $13.39 | — | $310.19 M | — | -76.21% | -56.55% | $13.2 / $1.47 | $4.53 |
| 5. | Hyperion DeFi, Inc. | $4.28 | — | $48.76 M | — | -38.69% | -3.24% | $17.18 / $1.02 | $4.73 |
| 6. | BioAtla, Inc. | $5.69 | — | $7.61 M | — | 732.7% | 543.76% | $71.5 / $3.92 | $-0.6 |
| 7. | IGC Pharma, Inc. | $0.32 | — | $31.52 M | — | -114.73% | -83.34% | $0.5 / $0.24 | $0.09 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -6.94 M | -4.95 M | -3.62 M | -3.21 M | -5.81 M |
| Net Profit | -7.12 M | -6.03 M | -4.75 M | -2.41 M | -6.46 M |
| EPS in Rs | -1.51 | -1.28 | -1.01 | -0.51 | -1.37 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -15.12 M | -5.26 M | -3.16 M | -3.17 M |
| Net Profit | -17.8 M | -0.54 M | -4.89 M | -3.66 M |
| EPS in Rs | -3.77 | -0.11 | -1.03 | -0.77 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 4.19 M | 7.22 M | 0.01 M | 0 M |
| Total Liabilities | 10.99 M | 7.68 M | 10.09 M | 5.94 M |
| Equity | -6.79 M | -0.46 M | -10.09 M | -5.94 M |
| Current Assets | 2.71 M | 5.73 M | 0 M | — |
| Current Liabilities | 10.74 M | 1.8 M | 4.18 M | 2.23 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -9.68 M | -7.72 M | -2.27 M | -2.15 M |
| Investing CF | -0.04 M | 0.72 M | -0.18 M | 0 M |
| Financing CF | 6.07 M | 10.93 M | 2.45 M | 1.9 M |
| Free CF | -9.73 M | -7.72 M | -2.27 M | -2.15 M |
| Capex | -0.05 M | — | — | — |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -3227.48% | 89.05% | -33.63% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-03-27 | 1:0.04 |
| 2025-10-13 | 1:0.125 |
| 2025-05-20 | 1:0.0666667 |
| 2025-01-27 | 1:0.01 |